Friday Pop Quiz 1/24/2025
In 2022 the FDA approved a medication for the treatment of the condition dipicted in the image. It inhibits the same enzymes as which of the following?
A. Ruxolitinib
B. Abrocitinib
C. Apremilast
D. Adalimumab
E. Tofacitinib
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
…
In 2022 the FDA approved a medication for the treatment of the condition dipicted in the image. It inhibits the same enzymes as which of the following?
A. Ruxolitinib
B. Abrocitinib
C. Apremilast
D. Adalimumab
E. Tofacitinib
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
Dr. John Harris, professor and chair of the dermatology department at UMass Chan Medical School, shared current challenges and knowledge gaps in treating pigmentary disorders in an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium. Watch as Dr. Harris explains how these knowledge gaps impact the patient’s experience, including their expectations of vi … 
Delivering effective dermatologic care for patients with skin of color requires a deep understanding of their unique needs. In her presentation at the Skin of Color Update, Dr. Amy McMichael, professor in the Department of Dermatology at Wake Forest School of Medicine, shared practical insights on managing non-scarring alopecia, emphasizing the importance of considering both biological and cultura … 
What is the most appropriate action in this otherwise healthy patient based on the image in the photograph?
A. Punch biopsy
B. Tissue culture
C. Reassurance
D. Plain film of the foot
E. Magnetic resonance imaging of the foot
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partners
… 
Welcome to the first issue of the Journal of Drugs in Dermatology for 2025! This issues focuses on the exciting advancements in aesthetic treatments, with editor’s picks that delve into cutting-edge topics shaping dermatology today. From the role of exosomes in cosmetic dermatology to expert insights on managing neuromodulator complications, this issue offers invaluable guidance for pr …